Sumitomo Mitsui Trust Group Inc. Boosts Stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Sumitomo Mitsui Trust Group Inc. grew its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 0.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,235,114 shares of the company's stock after purchasing an additional 4,907 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned approximately 0.47% of Ryan Specialty worth $79,245,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of RYAN. AQR Capital Management LLC purchased a new stake in Ryan Specialty in the second quarter valued at $261,000. Sanctuary Advisors LLC acquired a new stake in shares of Ryan Specialty during the second quarter worth about $802,000. GAMMA Investing LLC lifted its holdings in shares of Ryan Specialty by 106.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,249 shares of the company's stock valued at $83,000 after purchasing an additional 644 shares during the last quarter. UMB Bank n.a. boosted its position in shares of Ryan Specialty by 5.2% in the 3rd quarter. UMB Bank n.a. now owns 5,224 shares of the company's stock valued at $347,000 after purchasing an additional 256 shares during the period. Finally, Exchange Traded Concepts LLC purchased a new position in Ryan Specialty during the 3rd quarter worth approximately $761,000. Hedge funds and other institutional investors own 84.82% of the company's stock.

Insider Buying and Selling at Ryan Specialty

In other Ryan Specialty news, Director David P. Bolger sold 7,055 shares of the business's stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $70.88, for a total transaction of $500,058.40. Following the sale, the director now directly owns 78,149 shares in the company, valued at approximately $5,539,201.12. The trade was a 8.28 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Nicholas Dominic Cortezi sold 31,409 shares of the company's stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $65.64, for a total value of $2,061,686.76. Following the completion of the sale, the director now directly owns 2,697 shares in the company, valued at $177,031.08. This trade represents a 92.09 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 323,506 shares of company stock valued at $21,407,851. 11.10% of the stock is owned by company insiders.

Ryan Specialty Price Performance

Shares of RYAN traded up $1.45 during mid-day trading on Thursday, hitting $68.59. The company's stock had a trading volume of 1,277,517 shares, compared to its average volume of 974,697. The firm has a 50-day simple moving average of $65.60 and a 200 day simple moving average of $67.05. Ryan Specialty Holdings, Inc. has a 1-year low of $43.71 and a 1-year high of $75.97. The firm has a market capitalization of $17.96 billion, a P/E ratio of 89.08, a P/E/G ratio of 1.19 and a beta of 0.72. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Keefe, Bruyette & Woods reduced their price objective on Ryan Specialty from $79.00 to $77.00 and set an "outperform" rating for the company in a research note on Friday, January 10th. Morgan Stanley began coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They issued an "overweight" rating and a $90.00 price target for the company. Wells Fargo & Company decreased their price target on shares of Ryan Specialty from $68.00 to $64.00 and set an "equal weight" rating for the company in a research note on Tuesday, January 14th. Finally, Barclays lifted their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an "overweight" rating in a research note on Thursday, November 21st. One investment analyst has rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the company. According to data from MarketBeat, Ryan Specialty currently has an average rating of "Hold" and a consensus price target of $74.40.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.